Showing 1 - 4 results of 4 for search 'Silvia De Siervi', query time: 0.02s Refine Results
  1. 1
    SerpinB3 administration protects liver against ischemia-reperfusion injury

    SerpinB3 administration protects liver against ischemia-reperfusion injury by Cristian Turato, Mariapia Vairetti, Marta Cagna, Alessandra Biasiolo, Andrea Ferrigno, Santina Quarta, Mariagrazia Ruvoletto, Silvia De Siervi, Patrizia Pontisso, Laura Giuseppina Di Pasqua

    Published 2022-10-01
    Get full text
    Article
  2. 2
    VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference

    VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference by Stefano Conti Nibali, Silvia De Siervi, Enrico Luchinat, Andrea Magrì, Angela Messina, Lorenza Brocca, Stefania Mantovani, Barbara Oliviero, Mario U. Mondelli, Vito De Pinto, Cristian Turato, Cristina Arrigoni, Marco Lolicato

    Published 2024-06-01
    Get full text
    Article
  3. 3
    The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis

    The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis by Gianmarco Villano, Erica Novo, Cristian Turato, Santina Quarta, Mariagrazia Ruvoletto, Alessandra Biasiolo, Francesca Protopapa, Monica Chinellato, Andrea Martini, Elisabetta Trevellin, Marnie Granzotto, Stefania Cannito, Laura Cendron, Silvia De Siervi, Maria Guido, Maurizio Parola, Roberto Vettor, Patrizia Pontisso

    Published 2024-03-01
    Get full text
    Article
  4. 4
    PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)

    PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) by Stefania Angelicola, Francesca Giunchi, Francesca Ruzzi, Mariateresa Frascino, Mary Pitzalis, Laura Scalambra, Maria Sofia Semprini, Olga Maria Pittino, Chiara Cappello, Irene Siracusa, Ilaria Candida Chillico, Martina Di Noia, Cristian Turato, Silvia De Siervi, Francesco Lescai, Teresa Ciavattini, Giulia Lopatriello, Luca Bertoli, Hugo De Jonge, Luisa Iamele, Annalisa Altimari, Elisa Gruppioni, Andrea Ardizzoni, Marzia Rossato, Francesco Gelsomino, Pier-Luigi Lollini, Arianna Palladini

    Published 2025-01-01
    Get full text
    Article

Search Tools: